tm
Seeing Is Believing
tm
Seeing Is Believing
NovaBay Pharmaceuticals's activity chart (see below) currently has 2 price targets and 2 ratings on display.
Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 279.4 days.
Most recent stock forecast was given by EDWARD WOO from ASCENDIANT on 11-Nov-2024. First documented stock forecast 05-Jun-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Buy Since 30-Mar-2020
$2.81
$1.31 (87.33%)
$332.5
1 years 9 months 30 days ago
(11-Nov-2024)
2/3 (66.67%)
$0.46 (19.57%)
443
Buy
$3.8
$3.35 (744.44%)
3 years 30 days ago
(11-Aug-2023)
1/2 (50%)
$7.02 (252.09%)
183
Buy Since 13-Mar-2019
$1531.25
$1530.09 (131904.31%)
7 years 5 months 28 days ago
(13-Mar-2019)
1/1 (100%)
$421.9 (38.03%)
89
Buy Since 05-Jun-2017
$4900
$4898.79 (404858.69%)
$6737.5
8 years 5 months 15 days ago
(26-Mar-2018)
2/2 (100%)
$-9472.99 (-65.91%)
341
What is NBY (NovaBay Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on NBY (NovaBay Pharmaceuticals)?
Which analyst has the current lower performing score on NBY (NovaBay Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on NBY (NovaBay Pharmaceuticals)?
Which analyst is the currently most bullish on NBY (NovaBay Pharmaceuticals)?
Which analyst is the currently most reserved on NBY (NovaBay Pharmaceuticals)?
